Lawrence E. Bloch - 11 Jan 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role
President
Signature
/s/Lawrence Bloch
Issuer symbol
N/A
Transactions as of
11 Jan 2022
Net transactions value
$0
Form type
4
Filing time
12 Jan 2022, 16:00:50 UTC
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Lawrence E. Bloch filed Form 4 for INFINITY PHARMACEUTICALS, INC. on 12 Jan 2022."

Quick Takeaways

  • This page summarizes Lawrence E. Bloch's Form 4 filing for INFINITY PHARMACEUTICALS, INC..
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 12 Jan 2022, 16:00.

What Changed

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option (right to buy) Award $0 +335,000 $0.000000 335,000 11 Jan 2022 Common Stock 335,000 $1.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48th of the shares on January 31, 2022 and vests as to 1/48th of the shares at the end of each calendar month thereafter.

Sponsored